These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 25159665)
1. Female hippocampus vulnerability to environmental stress, a precipitating factor in Tau aggregation pathology. Sotiropoulos I; Silva J; Kimura T; Rodrigues AJ; Costa P; Almeida OF; Sousa N; Takashima A J Alzheimers Dis; 2015; 43(3):763-74. PubMed ID: 25159665 [TBL] [Abstract][Full Text] [Related]
2. Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation. Yu L; Wang W; Pang W; Xiao Z; Jiang Y; Hong Y J Alzheimers Dis; 2017; 57(2):475-482. PubMed ID: 28269786 [TBL] [Abstract][Full Text] [Related]
3. Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model. Orejana L; Barros-Miñones L; Aguirre N; Puerta E Exp Gerontol; 2013 Jun; 48(6):565-71. PubMed ID: 23501261 [TBL] [Abstract][Full Text] [Related]
5. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Van der Jeugd A; Ahmed T; Burnouf S; Belarbi K; Hamdame M; Grosjean ME; Humez S; Balschun D; Blum D; Buée L; D'Hooge R Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950 [TBL] [Abstract][Full Text] [Related]
6. Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy. Buccarello L; Grignaschi G; Castaldo AM; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T J Alzheimers Dis; 2017; 56(4):1279-1292. PubMed ID: 28157099 [TBL] [Abstract][Full Text] [Related]
7. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
8. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice. Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886 [TBL] [Abstract][Full Text] [Related]
9. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy. Yue M; Hanna A; Wilson J; Roder H; Janus C Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061 [TBL] [Abstract][Full Text] [Related]
10. Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid. Shan Y; Wang DD; Xu YX; Wang C; Cao L; Liu YS; Zhu CQ J Alzheimers Dis; 2016; 49(3):829-44. PubMed ID: 26577520 [TBL] [Abstract][Full Text] [Related]
11. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759 [TBL] [Abstract][Full Text] [Related]
12. Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model. Flunkert S; Hierzer M; Löffler T; Rabl R; Neddens J; Duller S; Schofield EL; Ward MA; Posch M; Jungwirth H; Windisch M; Hutter-Paier B Neurodegener Dis; 2013; 11(4):194-205. PubMed ID: 22797329 [TBL] [Abstract][Full Text] [Related]
14. T217-Phosphorylation Exacerbates Tau Pathologies and Tau-Induced Cognitive Impairment. Wang X; Liu Q; Li XG; Zhou QZ; Wu DQ; Li SH; Liu YC; Wang JZ J Alzheimers Dis; 2021; 81(4):1403-1418. PubMed ID: 33935099 [TBL] [Abstract][Full Text] [Related]
15. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM J Neurosci; 2011 Feb; 31(7):2511-25. PubMed ID: 21325519 [TBL] [Abstract][Full Text] [Related]
16. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317 [TBL] [Abstract][Full Text] [Related]
17. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo. Violet M; Chauderlier A; Delattre L; Tardivel M; Chouala MS; Sultan A; Marciniak E; Humez S; Binder L; Kayed R; Lefebvre B; Bonnefoy E; Buée L; Galas MC Neurobiol Dis; 2015 Oct; 82():540-551. PubMed ID: 26385829 [TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Laurent C; Eddarkaoui S; Derisbourg M; Leboucher A; Demeyer D; Carrier S; Schneider M; Hamdane M; Müller CE; Buée L; Blum D Neurobiol Aging; 2014 Sep; 35(9):2079-90. PubMed ID: 24780254 [TBL] [Abstract][Full Text] [Related]